| Earnings Per Share |
(11) Earnings Per Share
The following table sets forth the computation of earnings per share (amounts in thousands, except share and per share amounts):
|
|
|
13 Weeks Ended
|
|
|
39 Weeks Ended
|
|
|
|
|
September 29,
|
|
|
September 30,
|
|
|
September 29,
|
|
|
September 30,
|
|
|
|
|
2019
|
|
|
2018
|
|
|
2019
|
|
|
2018
|
|
|
Income from continuing operations
|
|
$
|
4,528
|
|
|
$
|
3,592
|
|
|
$
|
27,748
|
|
|
$
|
26,790
|
|
|
Income from discontinued operations, net of income taxes
|
|
|
—
|
|
|
|
9
|
|
|
|
—
|
|
|
|
30
|
|
|
Net income
|
|
$
|
4,528
|
|
|
$
|
3,601
|
|
|
$
|
27,748
|
|
|
$
|
26,820
|
|
|
Shares:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of common shares
outstanding - basic
|
|
|
28,951,612
|
|
|
|
29,720,472
|
|
|
|
29,159,922
|
|
|
|
29,708,055
|
|
|
Weighted average number of common shares
outstanding - diluted
|
|
|
29,191,076
|
|
|
|
30,358,284
|
|
|
|
29,563,396
|
|
|
|
30,370,193
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
0.16
|
|
|
$
|
0.12
|
|
|
$
|
0.95
|
|
|
$
|
0.90
|
|
|
Discontinued operations
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
Basic earnings per common share
|
|
$
|
0.16
|
|
|
$
|
0.12
|
|
|
$
|
0.95
|
|
|
$
|
0.90
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per common share:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$
|
0.16
|
|
|
$
|
0.12
|
|
|
$
|
0.94
|
|
|
$
|
0.88
|
|
|
Discontinued operations
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
|
—
|
|
|
Diluted earnings per common share
|
|
$
|
0.16
|
|
|
$
|
0.12
|
|
|
$
|
0.94
|
|
|
$
|
0.88
|
|
Diluted earnings per share for the third quarter of fiscal year 2019 excludes restricted shares of 44,565 which were outstanding during the period but were anti-dilutive and had no exercise price. There were no anti-dilutive shares for the third quarter of fiscal year 2018. Diluted earnings per share for the first thirty-nine weeks of fiscal year 2019 and 2018 excludes restricted shares of 28,011 and 727, respectively, which were outstanding during the period but were anti-dilutive and had no exercise price.
|